Commitments and Contingencies (Details Narrative) - USD ($) |
1 Months Ended | 6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Apr. 30, 2009 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Jun. 30, 2026 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
| Accounts payable | $ 4,653,644 | $ 4,807,655 | |||
| Amortized value | $ 1,779 | ||||
| Accrued interest | 220,845 | 220,845 | |||
| Patent expense reimbursement | 245,966 | $ 245,966 | |||
| Bonus compensation | $ 367,538 | $ 306,281 | |||
| License Agreement [Member] | The Henry M. Jackson Foundation ("HJF") [Member] | |||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
| Amortized period | 15 years | ||||
| Amortized value | $ 3,607 | ||||
| License Agreement [Member] | The Henry M. Jackson Foundation ("HJF") [Member] | |||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
| Shares issued during period common stock | 202,619 | ||||
| Shares issued price per share | $ 0.267 | ||||
| X | ||||||||||
- Definition Amortized period. No definition available.
|
| X | ||||||||||
- Definition Patent expense reimbursement amount. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|